Acute renal effects of the GLP-1 receptor agonist exenatide in overweight type 2 diabetes patients: a randomised, double-blind, placebo-controlled trial

Bibliographic Details
Main Authors:	Tonneijck, Lennart, Smits, Mark M., Muskiet, Marcel H. A., Hoekstra, Trynke, Kramer, Mark H. H., Danser, A. H. Jan, Diamant, Michaela, Joles, Jaap A., van Raalte, Daniël H.
Format:	Online
Language:	English
Published:	Springer Berlin Heidelberg 2016
Online Access:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4901099/

id	pubmed-4901099
recordtype	oai_dc
spelling	pubmed-49010992016-06-27 Acute renal effects of the GLP-1 receptor agonist exenatide in overweight type 2 diabetes patients: a randomised, double-blind, placebo-controlled trial Tonneijck, Lennart Smits, Mark M. Muskiet, Marcel H. A. Hoekstra, Trynke Kramer, Mark H. H. Danser, A. H. Jan Diamant, Michaela Joles, Jaap A. van Raalte, Daniël H. Article Springer Berlin Heidelberg 2016-04-01 2016 /pmc/articles/PMC4901099/ /pubmed/27038451 http://dx.doi.org/10.1007/s00125-016-3938-z Text en © The Author(s) 2016 Open Access This article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made.
repository_type	Open Access Journal
institution_category	Foreign Institution
institution	US National Center for Biotechnology Information
building	NCBI PubMed
collection	Online Access
language	English
format	Online
author	Tonneijck, Lennart Smits, Mark M. Muskiet, Marcel H. A. Hoekstra, Trynke Kramer, Mark H. H. Danser, A. H. Jan Diamant, Michaela Joles, Jaap A. van Raalte, Daniël H.
spellingShingle	Tonneijck, Lennart Smits, Mark M. Muskiet, Marcel H. A. Hoekstra, Trynke Kramer, Mark H. H. Danser, A. H. Jan Diamant, Michaela Joles, Jaap A. van Raalte, Daniël H. Acute renal effects of the GLP-1 receptor agonist exenatide in overweight type 2 diabetes patients: a randomised, double-blind, placebo-controlled trial
author_facet	Tonneijck, Lennart Smits, Mark M. Muskiet, Marcel H. A. Hoekstra, Trynke Kramer, Mark H. H. Danser, A. H. Jan Diamant, Michaela Joles, Jaap A. van Raalte, Daniël H.
author_sort	Tonneijck, Lennart
title	Acute renal effects of the GLP-1 receptor agonist exenatide in overweight type 2 diabetes patients: a randomised, double-blind, placebo-controlled trial
title_short	Acute renal effects of the GLP-1 receptor agonist exenatide in overweight type 2 diabetes patients: a randomised, double-blind, placebo-controlled trial
title_full	Acute renal effects of the GLP-1 receptor agonist exenatide in overweight type 2 diabetes patients: a randomised, double-blind, placebo-controlled trial
title_fullStr	Acute renal effects of the GLP-1 receptor agonist exenatide in overweight type 2 diabetes patients: a randomised, double-blind, placebo-controlled trial
title_full_unstemmed	Acute renal effects of the GLP-1 receptor agonist exenatide in overweight type 2 diabetes patients: a randomised, double-blind, placebo-controlled trial
title_sort	acute renal effects of the glp-1 receptor agonist exenatide in overweight type 2 diabetes patients: a randomised, double-blind, placebo-controlled trial
description
publisher	Springer Berlin Heidelberg
publishDate	2016
url	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4901099/
_version_	1613592320845807616

Acute renal effects of the GLP-1 receptor agonist exenatide in overweight type 2 diabetes patients: a randomised, double-blind, placebo-controlled trial

Similar Items